Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers

AIDS

Volumn 18, Issue 15, 2004, Pages 2009-2017

  Bunders, Madeleine ^a,b   Cortina Borja, Mario ^a   Thorne, Claire ^a   Kuijpers, Taco ^b   Newell, Marie Louise ^a   Giaquinto, C ^c   Rampon, O ^c   Giacomet, V ^c   De Rossi, A ^c   Grosch Worner, I ^d   Mok, J ^e   Bates, I ^f   de Jose, I ^f   Hawkins, F ^f   Garcia Rodriguez, M C ^f   Ladron de Guevara, C ^f   Ma Pena, J ^f   Gonzalez Garcia, J ^f   Arribas Lopez, J R ^f   Asensi Botet, F ^g   Otero, M C ^g   Perez Tamarit, D ^g   Orti, A ^g   San Miguel, M J ^g   Scherpbier, H ^h   Kreyenbroek, M ^h   Boer, K ^h   Bohlin, A B ⁱ   Belfrage, E ⁱ   Naver, L ⁱ   Levy, J ^j   Hainaut, M ^j   Peltier, A ^j   Goetghebuer, T ^j   Barlow, P ^j   Ferrazin, A ^k   Bassetti, D ^k   de Maria, A ^l   Gotta, C ^k   Mur, A ^m   Lopez Vilchez, M A ^m   Paya, A ^m   Carreras, R ^m   H Valerius, N ⁿ   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY OF PADOVA   (Italy)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^f HOSPITAL INFANTIL LA PAZ   (Spain)

^g HOSPITAL UNIVERSITARIO LA FE   (Spain)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^k UNIVERSITY OF GENOA   (Italy)

^l UNIVERSITY OF GENOA   (Italy)

^m UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

ⁿ HVIDOVRE HOSPITAL   (Denmark)

more..

Author keywords

Antiretroviral medication; Gender; Haematopoiesis; HIV 1; Race

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL COUNT; CELL LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RACE; REGRESSION ANALYSIS; SCHOOL CHILD; SCORING SYSTEM;

EID: 7744228997     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200410210-00005     Document Type: Article

References (26)

1. European Collaborative Study. HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS 2001, 15:761-770.
2. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, Berrebi A, Benifla JL, Burgard M, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001, 285:2083-2093.
3. Thorne C, Newell M-L for the European Collaborative Study. Are girls more at risk of intra-uterine-acquired HIV infection than boys? AIDS 2004, 18:344-347.
4. Mofenson LM, Munderi P. Safety of antiretroviral prophylaxis of perinatal transmission for HIV-Infected pregnant women and their infants. J Acquir Immune Defic Syndr 2002, 30:200-215.
5. Dainiak N, Worthington M, Riordan MA. 3′-Azido-3′- deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol 1988, 69:299-304.
6. Koch MA, Volberding PA, Lagakos SW, Booth DK, Pettinelli C, Myers MW, et al. Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/l or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group. Arch Intern Med 1992, 52:2286-2292.
7. Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS 2003, 17:2053-2061.
8. European Collaborative Study. Are there gender and race differences in cellular immunity patterns over age in infected and uninfected children born to HIV-infected women? J Acquir Immune Defic Syndr 2003, 33:635-641.
9. Friedman JH. Technical Report 25: A Variable Span Smoother. Stanford, CA: Laboratory for Computational Statistics, Stanford University; 1984.
10. Davison AC, Hinkley DV. Bootstrap Methods and their Application. Cambridge: Cambridge University Press; 2003.
11. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992, 11:1305-1319.
12. Carr R, Modi N, Dore C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev 2003, 3:CD003066.
13. Bamberg R, Johnson JP. Segmented neutrophil size and platelet morphology in HIV/AIDS patients. Clin Lab Sci 2002, 15:18-22.
14. Kuritzkes DR Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor. Clin Infect Dis 2000, 30:256-260.
15. Mandelbrot L, Peytavin G, Firtion G, Farinotti R. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women. Am J Obstet Gynecol 2001, 184:153-158.
16. Olivero OA, Shearer GM, Chouquet CA, Kovacs AA, Baker R, Stek AM, et al. Corporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1 positive mothers. Ann N Y Acad Sci 2000, 918:262-268.
17. Capparelli EV, Mirochnick M, Dankner WM, Blanchard S, Mofenson L, McSherry GD, et al. Pharmacokinetics and tolerance of zidovudine in preterm infants. J Pediatr 2003, 142:47-52.
18. Mirochnick M, Capparelli E, Connor JD. Pharmacokinetics of zidovudine in infants: a population analysis across studies. Clin Pharmacol Ther 1999, 66:16-24.
19. Baley JE, Stork EK, Warkentin PI, Shurin SB. Neonatal neutropenia. Clinical manifestations, cause, and outcome. Am J Dis Child 1988, 142:1161-1166.
20. Christensen RD, Harper TE, Rothstein G. Granulocyte-macrophage progenitor cells in term and preterm neonates. J Pediatr 1986, 109:1047-1051.
21. Rezvani K, Flanagan AM, Sarma U, Constantinovici N, Bain BJ. Investigation of ethnic neutropenia by assessment of bone marrow colony-forming cells. Acta Haematol 2001, 105:32-37.
22. Giordano TP, Wright JA, Hasan MQ, White ACJ, Graviss EA, Visnegarwala F. Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy? Clin Infect Dis 2003, 37:433-437.
23. Smith PR, Sarner L, Murphy MD, James B, Thomas JN, Aitken C. Ethnicity and discordance in plasma HIV-1 RNA viral load and CD4+ lymphocyte count in a cohort of HIV-1 infected individuals. J Clin Virol 2003, 26:101-107.
24. Anglaret X, Diagbouga S, Mortier E, Meda N, Verge-Valette V, Sylla-Koko F, et al. CD4+ T-Lymphocyte counts in HIV infection: are European standards applicable to African patients. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:361-367.
25. Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999, 354:1084-1089.
26. European Collaborative Study and the Swiss Mother and Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS 2000, 14:2913-2920.